MOSCA JOSEPH D has a total of 13 patent applications. Its first patent ever was published in 1995. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ETUBICS CORP, TIANJIN CANSINO BIOTECHNOLOGY INC and HOOKIPA BIOTECH AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Analysing materials | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Mosca Joseph D | 13 |
#2 | Hall Eric | 2 |
#3 | Kaushal Sumesh | 2 |
#4 | Gartner Suzanne | 2 |
#5 | La Russa Vince | 2 |
#6 | Kessler Steven | 2 |
#7 | Rosenberg Yvonne J | 1 |
#8 | Serres Pierre-Francis | 1 |
Publication | Filing date | Title |
---|---|---|
US2011262389A1 | Tumor-derived Biological Antigen Presenting Particles | |
WO2006031224A1 | Tumor-derived biological antigen presenting particles | |
WO03068925A2 | Production of a protein delivery system for in vivo therapeutic treatment | |
AU2002365933A1 | Production of recombinant therapeutic bioscavengers against chemical and biological agents | |
WO03027269A1 | Chronic pathogen-expressing cell lines | |
WO02079396A2 | Biological carriers for induction of immune responses | |
EP0796110A2 | System for the maintenance, growth and differentiation of human and non-human primate pluripotent stem, progenitor and mature bone marrow cells |